Project Details
| Short title | A Phase III Extension Study To Evaluate The Safety Of 10mg Atrasentan In Men With Hormone-Refractory Prostate Cancer. |
|---|---|
| Status | Finished |
| Effective start/end date | 1/01/02 → 31/12/05 |
Funding
- PPD GLOBAL LTD
A Phase III Extension Study To Evaluate The Safety Of 10mg Atrasentan In Men With Hormone-Refractory Prostate Cancer.
- James, Nicholas (Principal Investigator)